|
|
|
|
|
|
|
|
|
26.10.26 - 09:06
|
Could new US investment curbs complicate China′s biotech licensing surge? (SCMP)
|
|
|
Chinese biotech firms face fresh headwinds in their global expansion as Washington's proposed outbound investment restrictions threaten to disrupt deal structures, even though drug licensing agreements remain untouched for now, analysts say.
The US Treasury Department's draft rules released last week would “make it much harder for Chinese biotech firms to attract direct US investment or enter joint ventures”, according to David Zhang, an analyst at policy research firm Trivium China.
US Treasury......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24.10.26 - 00:01
|
US Family Annual Healthcare Plan Now Costs More Than $28K (Bloomberg)
|
|
|
Bloomberg's John Tozzi joins Scarlet Fu and Tom Keene on "Bloomberg Money." The annual cost of a US family's employer-provided healthcare plan reached an average $28,303 this year, 5% more than 2025, according to an annual survey conducted by health policy nonprofit KFF. (Source: Bloomberg)...
|
|
|
|
|
23.10.26 - 08:01
|
US Eyes Investment Curbs Against China Biotech Firms (Bloomberg)
|
|
|
“Bloomberg: The China Show” is your definitive source for news and analysis on the world's second-biggest economy. From politics and policy to tech and trends, Yvonne Man and David Ingles give global investors unique insight, delivering in-depth discussions with the newsmakers who matter. (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
